Company intelligence / Profile preview
BrickBio
Woburn/Boston area, Massachusetts, United Statesbrickbio.com ↗
- Ownership
- Private
- Employees
- ~4
- Development stage
- Preclinical
01
Overview
BrickBio has demonstrated strong preclinical results with its ADCs. Its lead candidate BRKB‑28 showed potent efficacy against breast and gastric cancers in vitro without affecting healthy cells. The company recently reported a fivefold increase in the therapeutic window of a PBD-based ADC targeting B7-H3/CD276 with complete tumor eradication in animal models.[9][10] No clinical-stage assets are publicly disclosed as of May 2025.
- Therapeutic areas
- OncologyNeurology
- Modalities
- Antibody-drug conjugates (ADCs)Bispecific antibody conjugatesNovel protein scaffoldsProtein origami therapeuticsSynthetic virology (AAV modification)
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
Request access →03
Partnerships
Abcam – partnership to incorporate conjugation-ready sites into recombinant antibodies across Abcam’s portfolio[4].Large pharmaceutical company for co-development of ADCs [6].*(Additional pharma partnerships implied but not all partners named.)*
Beyond the preview
Go deeper on BrickBio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BrickBio.